Blk

Blk, or B lymphoid kinase, is a Src family tyrosine kinase that shows B-lineage expression and tyrosine kinase activity, indicating a B-cell-restricted signaling role^[1]. Mechanistically, Blk links to B cell receptor biology because, in a COS-cell reconstitution system, only Blk among Lyn, Blk, Hck, Syk, and Fyn phosphorylated and associated with Igα/Igβ chimeras^[2]. In mice, Blk appears early in bone-marrow B-cell development and remains high in mature B cells, yet Blk-deficient mice showed unaltered B-cell development, activation, and humoral immune responses, supporting functional redundancy among Src family kinases^[3]. In disease genetics, variants upstream of BLK associate with systemic lupus erythematosus, while autoimmune BLK haplotypes show reduced BLK expression and altered B-cell activation phenotypes in rheumatoid arthritis models^[4][5]. Compared with related Src isoforms, Blk is distinguished by B-lineage enrichment, selective Igα/Igβ coupling in reconstituted BCR signaling, and redundancy rather than absolute requirement in mouse B-cell immunity^[1][2][3]. For experimental applications, activated Blk undergoes E6AP-mediated ubiquitination and proteasomal degradation, and selective irreversible BLK inhibitors provide chemical tools for probing BLK-dependent signaling^[6][7].